Sugi Predict

Sugi Predict / Compounds / SCHEMBL4246293

SCHEMBL4246293

SCHEMBL4246293

C#CCOc1c(F)cc(C(=O)NCC2CCCCC2C)cc1F

nearest known ligand 0.39

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 1/20 0.39
▸ TAS1R3 Q7RTX0 6/20 0.37
▸ TAS1R1 Q7RTX1 6/20 0.37
▸ TAS1R2 Q8TE23 6/20 0.37
▸ SCN9A Q15858 2/20 0.36
▸ P2RX3 P56373 2/20 0.34
▸ P2RX2 Q9UBL9 2/20 0.34
▸ CYP2C9 P11712 2/20 0.33
▸ MAPK14 Q16539 2/20 0.33
▸ HPGD P15428 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ KAT8 Q9H7Z6 1/20 0.33
▸ MAPK11 Q15759 1/20 0.33
▸ ABCG2 Q9UNQ0 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4252787 0.85 TDP1 (0.51) TDP1CYP2C9MAPK14KMT2AMAPK11
SCHEMBL4240818 0.84 TDP1 (0.53) TDP1KMT2A
SCHEMBL4242303 0.83 TAS1R3 (0.42) TAS1R3TAS1R1TAS1R2SCN9ACYP2C9
SCHEMBL4249949 0.83 TDP1 (0.48) TDP1CYP2C9MAPK14KMT2AMAPK11
SCHEMBL4249956 0.83 TDP1 (0.44) TDP1CYP2C9MAPK14MAPK11
SCHEMBL4247030 0.82 TAS1R3 (0.58) TAS1R3TAS1R1TAS1R2
SCHEMBL4246190 0.82 TAS1R3 (0.58) TAS1R3TAS1R1TAS1R2
SCHEMBL4246193 0.82 TAS1R3 (0.58) TAS1R3TAS1R1TAS1R2
SCHEMBL4242205 0.80 TAS1R3 (0.55) TAS1R3TAS1R1TAS1R2
SCHEMBL4248962 0.79 TDP1 (0.65) TDP1HPGDKMT2AABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7902400-B2 N-(1,1-diemthylpropyl)-4-(2-propynyloxy)-3-methoxybenzamide; N-(2,2-diemthylpropyl)-4-(2-propynyloxy)-3-methoxybenzamide; controlling plant diseases SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-03-08 — — US disclosed
US-7902400-B2 N-(1,1-diemthylpropyl)-4-(2-propynyloxy)-3-methoxybenzamide; N-(2,2-diemthylpropyl)-4-(2-propynyloxy)-3-methoxybenzamide; controlling plant diseases SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-03-08 — — US disclosed
US-7902400-B2 N-(1,1-diemthylpropyl)-4-(2-propynyloxy)-3-methoxybenzamide; N-(2,2-diemthylpropyl)-4-(2-propynyloxy)-3-methoxybenzamide; controlling plant diseases SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-03-08 — — US disclosed
US-20090131531-A1 Amide Compounds and their Use SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-05-21 — — US disclosed
US-20090131531-A1 Amide Compounds and their Use SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-05-21 — — US disclosed
US-20090131531-A1 Amide Compounds and their Use SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-05-21 — — US disclosed
EP-1940780-A1 AMIDE COMPOUNDS AND THEIR USE SUMITOMO CHEMICAL CO., LTD. (JP) 2008-07-09 — — EP disclosed
WO-2007049728-A1 AMIDE COMPOUNDS AND THEIR USE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-05-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131531-A1 Amide Compounds and their Use NAT1, ACAT2, NAAA TDP1 3052/4885TAS1R3 1939/4885TAS1R1 885/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.